Health

Golden State Killer Case Selected As 2019 DNA Hit Of The Year

The forty-five-year investigation resulted in arrest after law enforcement's use of investigative genetic genealogy KOBE, Japan, June 18, 2019 /PRNewswire/ -- Gordon Thomas Honeywell Governmental Affairs (GTH-GA) has announced that the Golden State Killer case was selected as the 2019 DNA Hit of...

2019-06-18 11:30 94

Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings

SUZHOU, China, June 18, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical results of CT103A, the potential best-in-class therapy of fully-human ...

2019-06-18 08:00 354

AXA Hong Kong, CUHK and Oxford VR join forces to revolutionise mental health care by launching Asia-first VR therapy solution

HONG KONG, June 17, 2019 /PRNewswire/ -- AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) have today jointly launched a first-of-its-kind advanced psychological therapy using virtual reality (VR) technology to support better mental health outcomes inAsia including the...

2019-06-17 19:45 474

The second Chengdu International Cosmetic Medicine Industry Conference and the "Capital of Cosmetic Medicine" summit forum opened in Chengdu on June 15, 2019

CHENGDU, China, June 17, 2019 /PRNewswire/ -- On June 15, the second Chengdu International Cosmetic Medicine Industry Conference and the "Capital of Cosmetic Medicine" summit forum, cosponsored by Chengdu People's Government, Sichuan Health Committee, and Chinese Association of Plastics andAesthe...

2019-06-17 17:56 331

How XAG is Leveraging AI Technology to Transform Agriculture

GENEVA ,Switzerland, June 17, 2019 /PRNewswire/ -- The 3rd AI for Good Global Summit, a leading United Nation platform for multilateral dialogue on Artificial Intelligence (AI), was kicked off inGeneva, Switzerland, May 28-31. As the only Chinese agri-tech company to join the Summit, XAG presente...

2019-06-17 15:48 393

Catalys Pacific Launches in Japan to Advance Early-Stage Life Sciences Innovation by Creating and Investing in Global Companies

TOKYO, June 17, 2019 /PRNewswire/ -- Catalys Pacific, a new venture capital firm inJapan built by a global team seasoned in life sciences investing, today announces the launch of its first fund. Leveraging its networks in academia, biotech, venture capital and the pharmaceutical industry, Catalys...

2019-06-17 14:00 343

Cedrus' Head of Life Sciences Invited to Moderate a Panel at China Focus@BIO and was a Panelist at the Redefining Early Stage Investments Conference in Philadelphia

HONG KONG, June 17, 2019 /PRNewswire/ -- Ms. Kimberly Nearing, Head of Life Sciences atCedrus Investments ("Cedrus") , was invited to moderate the first panel of the China Focus@BIO Conference in Philadelphia held on 2nd June 2019. Kim was also a panelist at the ...

2019-06-17 09:00 619

Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302 JAK Inhibitor for Ulcerative Colitis and Crohn's Disease

SHANGHAI, June 14, 2019 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone) announced today dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients with Ulcerative Colitis and Crohn's disease respectively. The Phase II studies ...

2019-06-14 20:30 821

First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"

HONG KONG, June 14, 2019 /PRNewswire/ -- On June 13, "The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held inHong Kong by Yulin Bagu Group JV LLC. The event was attended by the delegation of H.E.Bakhtiyor Saidov, Ambassador of Uzbekistan in C...

2019-06-14 12:48 2091

China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin

-  Chinese registrational clinical trial for lefamulin to begin in 2H 2019 BEIJING and SHANGHAI, June 14, 2019 /PRNewswire/ -- Sinovant Sciences today announced that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medica...

2019-06-14 09:00 1549

111 Signs Strategic Partnership Agreement with Tong Ren Tang Technologies to Advance "Internet + Healthcare"

SHANGHAI, June 13, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has signed a strategic partnership agreement with Tong Ren Tang Technologies Co., Ltd. ("Tong Ren Tang Technologies") (1666.HK),...

2019-06-14 01:45 5356

Inaugural Global Health Forum of Boao Forum for Asia Held In Qingdao

QINGDAO, China, June 13, 2019 /PRNewswire/ -- The inaugural Global Health Forum (GHF) of Boao Forum forAsia (BFA) was held in Qingdao, China, from June 10 to June 12. Aimed at gathering global consensus on healthcare, pooling wisdom and resources in the medical industry and public health field, a...

2019-06-13 21:34 1725

New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting

Data Presentation & Lunch Symposium at TVT2019 Structural Heart Summit CHICAGO, June 13, 2019 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 S...

2019-06-13 21:10 1273

Lumosa to Initiate Phase 2 Human Clinical Trial in the US and Taiwan for Its LT3001, A Novel Drug for the Treatment of Acute Ischemic Stroke

TAIPEI, Taiwan, June 13, 2019 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; code: 6535.TWO) announced that the company is ready to commence the Phase 2 proof of concept (PoC) study for its LT3001, a novel drug for the treatment of acute ischemic stroke (AIS) that showed good safety, tolerability...

2019-06-13 20:00 736

Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference

Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...

2019-06-13 20:00 4358

Fairmont Hotels & Resorts Maximizes its Global Occupancy and Welcomes Over 2 Million Well-Travelled Honeybees at its Properties Worldwide

-Fairmont Bee Sustainable launches new digital platform featuring live hive monitoring and in-depth honey analysis to increase awareness of global bee health-   PARIS, June 13, 2019 /PRNewswire/ -- To celebrate Pollinator Month, Fairmont Hotels & Resorts, a pioneer of responsible tourism and sou...

2019-06-13 19:27 1083

Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer

* The partnership will leverage Tessa Therapeutics' global operational capabilities and cell therapy platform technologies to target prevalent cancers inChina * The joint venture will be the sole licensee of Tessa Therapeutics' cell therapies for research, development and commercialization in...

2019-06-13 07:15 1010

ISTH President Claire McLintock Receives Officer of the New Zealand Order of Merit on Queen's Birthday Honours List

Award Underscores McLintock's Service to the Fields of Haematology & Obstetrics CHAPEL HILL, North Carolina, June 13, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) today announced that ISTH President Claire McLintock, MD, has received the award of Officer of t...

2019-06-13 02:00 1181

CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA

KFAR SABA, Israel, June 12, 2019 /PRNewswire/ -- CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully enrolled the 200th patient in the Agili-C™ IDE pivotal clinical study. Surgery was performed byScott ...

2019-06-12 20:38 1180

AlpVision to Offer the First Online Biological Neural Networks (BNN) Servers Subscription Services for Artificial Intelligence Researchers

VEVEY, Switzerland, June 12, 2019 /PRNewswire/ -- AlpVision SA, a pioneering information and communication technology company and a global leader in advanced signal processing applications, announces at the AI summit inLondon the release plan of bioserver.net, a new cloud computing service based ...

2019-06-12 15:00 1058
12345 ... 730